开盘$448.17
昨收$460.28
当日区间$447.04 – $462.91
成交量2.58M
市值$249.05B
市盈率（TTM）26.7
股息率2.16%
AMGN 相关新闻
匹配 Amgen 或代码 AMGN 的头条新闻，按最新排序。
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
- Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
- Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $457
- Setback for the second time in a week! Novartis (NVS.US) sees its blockbuster heart disease drug fail in Phase III trials, causing a sharp drop in share price; Amgen (AMGN.US) suffers collateral damage. 负面
- Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
- Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
- William Blair Maintains Amgen(AMGN.US) With Buy Rating
- Amgen Advances Tarlatamab Shot Vs. Infusion in Phase 3 Lung Cancer Study
- Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $457 正面
- A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $317 to $452
- Citi Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $405
- BMO Capital Downgrades Amgen(AMGN.US) to Hold Rating, Maintains Target Price $450 负面
- Amgen | 3: Initial statement of beneficial ownership of securities- Dittrich Thomas J.W.
- Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $500
暂无评论——快来第一个聊聊 AMGN。
登录后参与讨论。